InvestorsHub Logo
icon url

Alapis

11/08/13 9:28 AM

#88491 RE: alexander77 #88490

With orphan drug status you can reduce the time frame significantly as you should know! Plus there is much research done in GDNF already !
icon url

Skeetz99

11/08/13 11:19 AM

#88498 RE: alexander77 #88490

In regards to tax loss selling; it starts in October (not December ...related to the Biotech industry). In regards to MANF; did you ever do any research on "Orphan Drug" strategy?

You can start by looking up more about Amgen (and its history overall). Orphan strategy - will accelerate the timelines...and open up the possibility of getting potential Pharma. drug partnering as well.